Michael A. Boxer net worth and biography

Michael Boxer Biography and Net Worth

Michael A. Boxer is Senior Vice President, General Counsel of the Company. Mr. Boxer joined the company as Senior Vice President and General Counsel in January 2018. Prior to joining the company, Mr. Boxer was Executive Vice President and Group General Counsel at Luxottica, a leading global vision care company, from May 2011 to December 2017, and prior to that he held various positions of increasing responsibility at Luxottica.

What is Michael A. Boxer's net worth?: The estimated net worth of Michael A. Boxer is at least $7.41 million as of February 7th, 2024. Mr. Boxer owns 12,901 shares of Thermo Fisher Scientific stock worth more than $7,414,463 as of April 26th. This net worth estimate does not reflect any other assets that Mr. Boxer may own. Learn More about Michael A. Boxer's net worth.
How do I contact Michael A. Boxer?: The corporate mailing address for Mr. Boxer and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Michael A. Boxer's contact information.
Has Michael A. Boxer been buying or selling shares of Thermo Fisher Scientific?: Michael A. Boxer has not been actively trading shares of Thermo Fisher Scientific within the last three months. Most recently, Michael A. Boxer sold 14,566 shares of the business's stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $562.00, for a transaction totalling $8,186,092.00. Following the completion of the sale, the senior vice president now directly owns 12,901 shares of the company's stock, valued at $7,250,362. Learn More on Michael A. Boxer's trading history.
Who are Thermo Fisher Scientific's active insiders?: Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Marc Casper (CEO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Jim Manzi (Director), Gianluca Pettiti (EVP), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.
Are insiders buying or selling shares of Thermo Fisher Scientific?: During the last twelve months, Thermo Fisher Scientific insiders bought shares 1 times. They purchased a total of 4 shares worth more than $2,104.60. During the last twelve months, insiders at the medical research company sold shares 14 times. They sold a total of 110,577 shares worth more than $59,726,166.22. The most recent insider tranaction occured on March, 12th when CEO Marc N Casper sold 10,000 shares worth more than $5,979,800.00. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.
Information on this page was last updated on 3/12/2024.

Michael A. Boxer Insider Trading History at Thermo Fisher Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/7/2024	Sell	14,566	$562.00	$8,186,092.00	12,901
6/26/2023	Buy	4	$526.15	$2,104.60	13,101
8/8/2022	Sell	7,283	$590.80	$4,302,796.40	12,398

Michael A. Boxer Buying and Selling Activity at Thermo Fisher Scientific

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $573.60

$566.95

$575.00

50 Day Range

MA: $573.08

$541.78

$599.43

2 Week Range

Now: $573.60

$415.60

$603.82

Volume

1,437,037 shs

Average Volume

1,556,345 shs

Market Capitalization

$218.95 billion

P/E Ratio

36.79

Dividend Yield

0.27%

Beta

0.8

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>